IL-6 deficiency in mice neither impairs induction of metabolic genes in the liver nor affects blood glucose levels during fasting and moderately intense exercise.
OBJECTIVE
Fasting and exercise are strong physiological stimuli for hepatic glucose production. IL-6 has been implicated in the regulation of gluconeogenic genes, but the results are contradictory and the relevance of IL-6 for fasting- and exercise-induced hepatic glucose production is not clear.


METHODS
Investigations were performed in rat hepatoma cells, and on C57Bl6 and Il6(-/-) mice under the following conditions: IL-6 stimulation/injection, non-exhaustive exercise (60 min run on a treadmill) and fasting for 16 h. Metabolite analysis, quantitative real-time PCR and immunoblotting were performed.


RESULTS
IL-6 stimulation of rat hepatoma cells led to higher glucose production. Injection of IL-6 in mice slightly increased hepatic Pepck (also known as Pck1) expression. Fasting of Il6(-/-) mice for 16 h did not alter glucose production compared with wild-type mice, since plasma glucose concentrations were similar and upregulation of phosphoenolpyruvate carboxykinase (PEPCK) and Pgc-1alpha (also known as Ppargc1a) expression was comparable. In the non-fasting state, Il6(-/-) mice showed a mild metabolic alteration including higher plasma glucose and insulin levels, lower NEFA concentrations and slightly increased hepatic PEPCK content. Moderately intense exercise resulted in elevated IL-6 plasma levels in wild-type mice. Despite that, plasma glucose, insulin, NEFA levels and hepatic glycogen content were not different in Il6(-/-) mice immediately after running, while expression of hepatic G6pc, Pgc-1alpha, Irs2 and Igfbp1 mRNA was similarly increased.


CONCLUSIONS
These data suggest that in mice IL-6 is not essential for physiologically increased glucose production during fasting or non-exhaustive exercise.
Fritsche
L
L
Department of Internal Medicine, Division of Pathobiochemistry and Clinical Chemistry, University of Tuebingen, Otfried-Mueller-Strasse 10, 72076 Tuebingen, Germany.
Hoene
M
M
Lehmann
R
R
Ellingsgaard
H
H
Hennige
A M
AM
Pohl
A K
AK
Häring
H U
HU
Schleicher
E D
ED
Weigert
C
C
D000818:Animals; D001786:Blood Glucose / Q000235:genetics / Q000378:metabolism*; D015153:Blotting, Western; D002478:Cells, Cultured; D005215:Fasting / Q000378:metabolism*; D015870:Gene Expression / Q000187:drug effects / Q000502:physiology; D005943:Gluconeogenesis / Q000235:genetics; D006003:Glycogen / Q000235:genetics / Q000378:metabolism; D007328:Insulin / Q000235:genetics / Q000378:metabolism; D015850:Interleukin-6 / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D019764:Phosphoenolpyruvate Carboxykinase (ATP) / Q000235:genetics / Q000378:metabolism; D010805:Physical Conditioning, Animal / Q000502:physiology*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats
D001786:Blood Glucose; D007328:Insulin; D015850:Interleukin-6; D012333:RNA, Messenger; D006003:Glycogen; D019764:Phosphoenolpyruvate Carboxykinase (ATP)
FASEB J. 2004 Jun;18(9):992-4
15059966
Cell Metab. 2006 Apr;3(4):267-75
16581004
Endocrinology. 2004 Jun;145(6):2680-6
14988384
Diabetes. 2006 Dec;55 Suppl 2:S48-54
17130644
J Clin Endocrinol Metab. 1997 Dec;82(12):4167-70
9398733
J Physiol. 2003 Jan 1;546(Pt 1):299-305
12509497
J Appl Physiol (1985). 2005 Feb;98(2):477-81
15448117
Nat Med. 2004 Feb;10(2):168-74
14716305
J Biol Chem. 2006 Mar 17;281(11):7060-7
16418171
J Clin Endocrinol Metab. 2001 Mar;86(3):1154-9
11238501
Hepatology. 2002 Jan;35(1):40-8
11786958
Diabetologia. 2010 Mar;53(3):399-402
20012010
Mol Endocrinol. 2009 Jun;23(6):827-37
19264844
Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E405-8
16219665
Cell Metab. 2007 Jun;5(6):438-49
17550779
Am J Physiol Endocrinol Metab. 2004 Jul;287(1):E182-7
15191885
Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E616-21
15149950
Metabolism. 1995 Feb;44(2):145-6
7869907
Hepatology. 1994 Dec;20(6):1577-83
7527006
Diabetes. 2006 Oct;55(10):2688-97
17003332
J Appl Physiol (1985). 2009 Dec;107(6):1830-9
19850730
Anal Biochem. 1976 Mar;71(1):96-105
1275237
J Physiol. 2000 Nov 15;529 Pt 1:237-42
11080265
Annu Rev Nutr. 2007;27:329-45
17465853
Diabetes. 2007 Jun;56(6):1630-7
17363741
Science. 1996 Nov 22;274(5291):1379-83
8910279
Histochem Cell Biol. 2007 Oct;128(4):371-7
17805558
Diabetes Care. 2005 Aug;28(8):2007-12
16043746
Am J Physiol Endocrinol Metab. 2001 Apr;280(4):E650-6
11254473
Am J Physiol Cell Physiol. 2007 Sep;293(3):C1139-47
17615159
J Physiol. 2009 Jan 15;587(1):241-52
19001047
Mol Cell Biol. 2001 Jan;21(2):414-24
11134330
Am J Physiol. 1990 Jan;258(1 Pt 1):E57-64
2105658
FASEB J. 2003 Nov;17(14):2166-8
12958150
Biochem Biophys Res Commun. 1990 Jun 15;169(2):623-8
2357222
Am J Physiol. 1997 Aug;273(2 Pt 1):E262-7
9277378
Biochem J. 2003 Aug 15;374(Pt 1):1-20
12773095
Mol Endocrinol. 2006 Dec;20(12):3364-75
16945991
Nat Med. 2002 Jan;8(1):75-9
11786910
J Clin Endocrinol Metab. 2003 Jul;88(7):3005-10
12843134
Eur J Appl Physiol. 2010 Feb;108(3):557-66
19865828
Diabetes. 2004 Jul;53(7):1643-8
15220185
Adv Exp Med Biol. 1998;441:117-27
9781319
Cell Metab. 2008 Jul;8(1):49-64
18590692
JAMA. 2001 Jul 18;286(3):327-34
11466099
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13163-8
18719127
Hepatology. 2001 Jun;33(6):1377-86
11391526